Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures

US9757463B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9757463-B2
Application numberUS-201514918115-A
CountryUS
Kind codeB2
Filing dateOct 20, 2015
Priority dateJun 15, 2012
Publication dateSep 12, 2017
Grant dateSep 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for making a polymer, the method comprising polymerizing glycidol in the presence of a tin catalyst to form the polymer, the polymer comprising at least one repeating unit formed from a monomer selected from: or a combination thereof. 2. The method of claim 1 , wherein the tin catalyst is Sn(OTf) 2 . 3. The method of claim 1 , further comprising the step of crosslinking the polymer with crosslinks, wherein the crosslinks comprise one or more of wherein at least one of is not 0. 4. The method of claim 1 , wherein polymerizing glycidol in the presence of the tin catalyst is performed at a temperature of from −80° C. to 50° C. 5. The method of claim 1 , further comprising crosslinking the polymer. 6. The method of claim 1 , wherein the tin catalyst is a tin (II) catalyst. 7. A method for making a polymer, the method comprising polymerizing glycidol in a presence of a tin catalyst to form the polymer, the polymer comprising repeating units selected from: wherein R 0 is selected from H, alkyl, NH 2 , and R 1 ; wherein R 1 comprises a crosslinking functionality; wherein repeating units A1, A2, B1, and B2 account for at least about 50 wgt % of the polymer; and wherein the ratio of (A1+A2):(B1+B2) is greater than 5. 8. The method of claim 7 , wherein the tin catalyst is a tin (II) catalyst. 9. The method of claim 8 , wherein the tin (II) catalyst is Sn(OTf) 2 . 10. The method of claim 7 , wherein polymerizing glycidol in the presence of the tin catalyst is performed at a temperature of from −80° C. to 50° C. 11. A method of forming a nanoparticle comprising: polymerizing glycidol in a presence of a tin catalyst to form a polymer, the polymer comprising at least one repeating unit formed from a monomer selected from: or a combination thereof; and crosslinking the polymer with crosslinks, wherein the crosslinks comprises wherein at least one of is not 0, thereby forming the nanoparticle. 12. The method of claim 11 , wherein the tin catalyst is a tin (II) catalyst. 13. The method of claim 12 , wherein the tin (II) catalyst is Sn(OTf) 2 . 14. The method of claim 11 , wherein polymerizing glycidol in the presence of the tin catalyst is performed at a temperature of from −80° C. to 50° C.

Assignees

Inventors

Classifications

  • Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide) · CPC title

  • Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title

  • Chemical after-treatment · CPC title

  • aromatic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9757463B2 cover?
Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Who is the assignee on this patent?
Univ Vanderbilt
What technology area does this patent fall under?
Primary CPC classification A61K47/34. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).